Vycor Medical, Inc. (VYCO)
OTCMKTS · Delayed Price · Currency is USD
0.0380
0.00 (0.00%)
At close: Oct 20, 2026

Vycor Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.811.861.591.461.221.39
Revenue Growth
1.61%17.24%8.81%19.43%-12.20%21.97%
Gross Profit
1.511.561.421.321.081.26
Operating Income
0.050.03-0.010.04-0.31-0.44
Net Income
-0.38-0.4-0.43-0.39-0.73-0.76
Earnings Per Share
-0.01-0.01-0.01-0.01-0.02-0.03
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Vycor Medical
1.741.81.521.381.131.27
Nova Vision
0.070.070.070.080.090.12
Total
1.811.861.591.461.221.39

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.160.090.110.060.040.09
Total Debt
0.961.011.061.110.990.87
Net Cash (Debt)
-0.8-0.92-0.95-1.05-0.96-0.78
Net Cash Growth
------
Net Cash Per Share
-0.02-0.03-0.03-0.03-0.03-0.03

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.06-0.010.060.03-0.220.02
Capital Expenditures
-0-0.01-0.01-0.01-0-0.04
Free Cash Flow
0.06-0.020.050.02-0.22-0.02
Free Cash Flow Growth
--173.12%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
83.37%83.78%89.50%90.08%88.50%90.33%
Operating Margin
2.67%1.82%-0.57%2.75%-25.06%-31.30%
Pretax Margin
-3.12%-3.77%-6.73%-4.32%-32.68%-29.31%
Profit Margin
-21.26%-21.29%-27.15%-26.98%-59.63%-54.56%
FCF Margin
3.31%-1.00%3.44%1.37%-17.97%-1.22%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
21.21-42.61125.67--
PS Ratio
0.702.171.471.732.392.16